文献速递肾小球疾病

CCR6/CCL20轴扩增RORγt+调节性T细胞以保护免受肾小球肾炎

The CCR6/CCL20 axis expands RORγt+ Tregs to protect from glomerulonephritis.
PubMed 文献 · Kidney Int · 2023-03-15

研究通过将含或不含RORγt+ Treg的CD4+ T细胞过继转移至RAG1敲除小鼠并诱导肾毒性肾炎模型,发现RORγt+ Treg缺失显著加重肾损伤,且CCR6+亚群作用最强;CCL20通过CCR6信号介导其扩增与活化;抗中性粒细胞胞质抗体相关肾小球肾炎患者肾活检CCR6+ Treg增多且CCL20分泌增强。

要点

  • RORγt+ Treg缺失显著加重肾毒性肾炎小鼠的肾损伤,总体具有肾脏保护作用。
  • CCR6+ RORγt+ Treg亚群作用最强,其缺失显著恶化肾小球肾炎。
  • CCL20通过CCR6信号介导RORγt+ Treg的扩增与活化。

核心结论

  • RORγt+ Treg是肾小球肾炎的抗炎介质,并被认为是Treg导向疗法的有前景靶点。

研究设计与样本

  • 将含或不含RORγt+ Treg的纯化CD4+ T细胞过继转移至免疫缺陷RAG1敲除小鼠,并诱导肾毒性肾炎模型。
  • 比较21例抗中性粒细胞胞质抗体相关肾小球肾炎患者与31例健康活体供者肾活检中CCR6+ Treg及CCL20分泌。

主要发现

  • RORγt+ Treg缺失显著加重肾损伤,证明其总体肾脏保护特性。
  • RORγt+ Treg广泛免疫抑制,对特定类型T细胞应答无偏好。
  • RORγt+ Treg具有独特功能和转录谱,包括IL-10产生增强。
  • CCR6表达标记特别有效的亚群,其缺失显著恶化肾小球肾炎。
  • CCL20通过受体CCR6信号介导RORγt+ Treg的扩增和活化。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Previous studies have identified a unique Treg population, which expresses the Th17 characteristic transcription factor RORγt. These RORγt+ Tregs possess enhanced immunosuppressive capacity, which endows them with great therapeutic potential. However, as a caveat, they are also capable of secreting pro-inflammatory IL-17A. Since the sum function of RORγt+ Tregs in glomerulonephritis (GN) remains unknown, we studied the effects of their absence. Purified CD4+ T cell populations, containing or lacking RORγt+ Tregs, were transferred into immunocompromised RAG1 knockout mice and the nephrotoxic nephritis model of GN was induced. Absence of RORγt+ Tregs significantly aggravated kidney injury, demonstrating overall kidney-protective properties. Analyses of immune responses showed that RORγt+ Tregs were broadly immunosuppressive with no preference for a particular type of T cell response. Further characterization revealed a distinct functional and transcriptional profile, including enhanced production of IL-10. Expression of the chemokine receptor CCR6 marked a particularly potent subset, whose absence significantly worsened GN. As an underlying mechanism, we found that chemokine CCL20 acting through receptor CCR6 signaling mediated expansion and activation of RORγt+ Tregs. Finally, we also detected an increase of CCR6+ Tregs in kidney biopsies, as well as enhanced secretion of chemokine CCL20 in 21 patients with anti-neutrophil cytoplasmic antibody associated GN compared to that of 31 healthy living donors, indicating clinical relevance. Thus, our data characterize RORγt+ Tregs as anti-inflammatory mediators of GN and identify them as promising target for Treg directed therapies.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Herrnstadt GR, Niehus CB, Ramcke T, et al. The CCR6/CCL20 axis expands RORγt+ Tregs to protect from glomerulonephritis. Kidney Int. 2023. PMID: 36924892. doi:10.1016/j.kint.2023.02.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。